CMS has issued the Medicare Part B average sales price (ASP) files for the first quarter of 2013. CMS notes that average drug prices in the market generally remain relatively stable, with prices for the top Part B drugs decreasing by 1.2% on average. CMS also states that due to certain “operational issues,” it
average sales price (ASP)
OIG Report on Medicare Part B Drug Pricing Data
The OIG has released its latest report comparing Part B drug average sales prices (ASP) and average manufacturer prices, this one comparing first quarter 2012 ASPs and AMPs and their impact on Medicare reimbursement for the third quarter of 2012. By way of background, the Social Security Act requires the OIG to notify the…
CMS Finalizes OPPS, ASC Rates and Policies for 2013
On November 15, 2012, the Centers for Medicare & Medicaid Services (CMS) published its publishing its final rule with comment period updating Medicare payment and other policies for the hospital outpatient prospective payment system (OPPS) and ambulatory surgical centers (ASCs) for CY 2013. The rule also updates Medicare quality reporting program policies and various other Medicare policies. Key provisions of the final rule include the following:Continue Reading CMS Finalizes OPPS, ASC Rates and Policies for 2013
CMS Releases October 2012 Update to Medicare Part B Drug ASP Files
CMS has posted the October 2012 update to Medicare Part B average sales price (ASP) files, which will be used to pay for Part B covered drugs for the fourth quarter of 2012. CMS reports that drug prices in the market remain relatively stable, with average prices for the top Part B drugs decreasing…
April 2012 Medicare ASP Drug Pricing Files Posted
CMS has posted the April 2012 Medicare average sales price (ASP) files. According to CMS, average drug prices in the market remain relatively stable, with prices for the top Part B drugs decreasing by an average of 0.6%. CMS also notes that while it is authorized to substitute average manufacturer price (AMP) for the ASP…